Physician profile
Brittany Beard
NPI 1619682408
$1,997.46
in general payments reported to CMS, 2019-2025
17 companies · $796 in 2025
The $796 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $475 · 2024: $727 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $417.64 | 2023-2025 | |
| Novo Nordisk INC | $409.36 | 2023-2025 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $240.06 | 2023-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $179.55 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $162.19 | 2023-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $139.18 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $121.82 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Glaxosmithkline, LLC. | $76.55 | 2024-2025 | Trelegy Ellipta, Bexsero, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $46.20 | 2023-2024 | |
| Hologic Sales and Service, LLC | $35.01 | 2025 | Aptima |
| Gilead Sciences, INC. | $29.84 | 2024 | |
| Phathom Pharmaceuticals, INC. | $29.35 | 2024-2025 | Voquezna |
| Alkermes, INC. | $26.39 | 2024 | Vivitrol |
| Viiv Healthcare Company | $26.11 | 2024 | Dovato |
| Biogen, INC. | $20.05 | 2025 | Zurzuvae |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $19.86 | 2025 | Flucelvax, Fluad |
| Teva Pharmaceuticals USA, INC. | $18.30 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Beard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.